Digital Health Meetings

Share learnings, successes and ideas with peers from payor, provider, pharmaceutical, health care and technology organizations.

HealthXL Meetings are private group meetings limited to 8 - 12 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into topics like digital therapeutics, patient support, telehealth, clinical trials, oncology and many more. In Virtual Meetings, there is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Find your group of peers below:

Telemedicine & Virtual Care Delivery
12th December @ 10:45AM EDT

Masterclass: Partnering with Health Systems in Digital Health

Are you working in digital health and looking for successful partnerships with health systems? Join this meeting to deep dive into this topic with other senior leaders in this field.

Michael Freni
Featuring
Michael Freni
Vice President, Business Development, Innovation & Venture Partner, A.I. Digital Innovation Fund, Mass General Brigham
Digital Therapeutics (DTx)
13th December @ 10:45AM EDT

Masterclass: Key Considerations for Inclusion on the Evernorth Digital Health Formulary

How do DTx products get listed on a formulary? And what happens next? Join this masterclass to hear from Mark Bini, the visionary who helped devise Evernorth's Digital Health Formulary.

Mark Bini
Featuring
Mark Bini
Chief Patient Experience Officer at Evernorth
Digital Therapeutics (DTx)
13th December @ 10AM GMT / 6PM AWST

Masterclass: Future EU Regulations for AI in Medical Devices

Are you trying to commercialize AI-based digital health solutions in the European Union (EU)? Would you like to learn practical steps on how to navigate the EU regulations for AI in medical devices? Join us in this masterclass led by Erik Vollebregt (Partner at Axon Lawyers) to deep dive into this topic.

Erik Vollebregt
Featuring
Erik Vollebregt
Partner, Axon Lawyers
Digital Therapeutics (DTx)
14th December @ 10:45 AM EDT

Innovative Distribution Strategies for DTx

Currently, there is no one-size-fits-all strategy for DTx distribution. Join HealthXL in this meeting to discuss this topic further with your peers working in this space.

Francesca Wuttke
Featuring
Francesca Wuttke
CEO and Founder, nen Health
Digital Health in Oncology
15th December @ 10:45AM EDT

Innovation Showcase: Remote Patient Monitoring Programs in Oncology

In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.

Mark Grossman
Featuring
Mark Grossman
VP Growth Strategies , GoMo Health
Digital Therapeutics (DTx)
15th December @ 10:45 AM EDT

Masterclass: DTx Access Negotiation and Contracting with Commercial Health Plans in the US

Are you seeking reimbursement of a DTx solution in the US? Join this Masterclass led by Mike Pace to deep dive into this topic with your peers working in this space.

Michael Pace
Featuring
Michael Pace
CEO & Founder at PalmHealth.co
Digital Mental Health & Neurology
20th December @ 10:45AM EDT

The Intersection between DTx and Human Coaching in Mental Health

The connection between DTx and human coaching in mental health can weave together a more precise, personalized, and connected care experience. Apply now to join this meeting to discuss this topic further with your peers.

Eugene Borukhovich
Featuring
Eugene Borukhovich
COO & Co-Founder of YourCoach.Health
Digital Therapeutics (DTx)
21st December @ 10:45AM EDT

Sprint: Pharma Sales Model for DTx-Drug Combination (Part 2)

While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. Join this 2 part sprint to establish 5 key challenges and agree on 5 key recommendations with your peers working in this space.

John Cairns
Featuring
John Cairns
Global Head of Digital, Oncology Franchise, Sanofi
Digital Therapeutics (DTx)
10th January @ 10:45AM EDT

Sprint: How Can DTx Companies De-Risk Combination Products for Better Pharma Adoption? (Part 1)

Pharma companies are not risk takers, and adding a DTx to their products can be seen as a threat rather than a value-add. In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. Seats are limited so apply now to secure your place.

Orel Swenson, M.D, MBA
Featuring
Orel Swenson, M.D, MBA
Director Business Development & Strategy, Biofourmis
Digital Therapeutics (DTx)
11th January @ 10:45AM EDT

Revenue Generation in Pharma-DTx Partnerships

Please bear with us. This meeting under construction, details will follow shortly.
Ronny Hashmonay
Featuring
Ronny Hashmonay
Global Head of Business Transformation at Novartis
Telemedicine & Virtual Care Delivery
12th January @ 10:45AM EDT

Masterclass: Human-Centered Design in Digital Health: Case Studies

In this masterclass, we will touch on different case studies of human-centered design in digital health. Spaces are limited so apply now to secure your seat.

Kellee M. Franklin, PhD
Featuring
Kellee M. Franklin, PhD
Founder | Mindful Innovator, Mindful Innovation Labs
Telemedicine & Virtual Care Delivery
17th January @ 10:45AM EDT

How Can Virtual Care Solutions Help Health Systems Bounce Back After Covid?

Health systems have been shocked in a way that has never been seen before with the COVID-19 pandemic. Join HealthXL in this meeting to discuss this topic with your peers working in this space.

Michael Freni
Featuring
Michael Freni
Vice President, Business Development, Innovation & Venture Partner, A.I. Digital Innovation Fund, Mass General Brigham
Telemedicine & Virtual Care Delivery
18th January @ 10:45AM EDT

Digital Health for Trigger Management in Autoimmune Conditions

It can be hard for HCPs to provide precise medical decisions in autoimmune conditions due to the patient variability and the trigger events not being fully understood. Join other senior leaders in this meeting to discuss this topic further.

Melinda Decker
Featuring
Melinda Decker
Fractional Chief Commercial Officer, Digital Health
Digital Therapeutics (DTx)
18th January @ 10:45AM EDT

Increase DTx Market Access and Adoption via Precision Patient Engagement

Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Apply now to deep dive into this topic with your peers working in this space.

Bob Gold
Featuring
Bob Gold
Founder and Chief Behavioral Technologist, GoMo Health
Digital Therapeutics (DTx)
23rd January @ 10:45AM EDT

Masterclass: How to Move from DTx Point Solutions to Platforms?

Why is now the right time to move from DTx point solutions to platforms? How to bring this to life? Join this meeting to discuss this topic further with your peers. Apply now to secure your seat.

Abhishek Shah
Featuring
Abhishek Shah
CEO, Wellthy Therapeutics
Digital Therapeutics (DTx)
25th January @ 10:45AM EDT

Masterclass: FDA Breakthrough Designation: How Can DTx Companies Navigate it?

Getting regulatory clearance/approval for DTx can be challenging, and it requires a learning curve to define the best regulatory strategy for a specific solution. Join this Masterclass to deep dive into this topic further.

Tim Marjenin
Featuring
Tim Marjenin
Vice President of Neurology Regulatory Affairs, MCRA
Digital Therapeutics (DTx)
26th January @ 10:45AM EDT

Sprint: How Can DTx Companies De-Risk Combination Products for Better Pharma Adoption? (Part 2)

Pharma companies are not risk takers, and adding a DTx to their products can be seen as a threat rather than a value-add. In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. Seats are limited so apply now to secure your space.

Orel Swenson, M.D, MBA
Featuring
Orel Swenson, M.D, MBA
Director Business Development & Strategy, Biofourmis
Telemedicine & Virtual Care Delivery
26th January @ 11AM EDT

HealthXL Webinar: Retail Healthcare: Current and Future Opportunities for Digital Health

Are we entering the era of retail health and retail medicine? What role does digital health play in retail healthcare? Join HealthXL in this webinar where we will deep dive into this topic with Adam Pellegrini (former SVP Enterprise Virtual Care & Consumer Health Innovation at CVS, former VP Digital Health at Walgreens, currently CEO at Jasper Health).

Adam Pellegrini
Featuring
Adam Pellegrini
CEO & Co-Founder, Jasper Health
Digital Health in Oncology
31st January @ 10:45AM EDT

Are Hospitals the Right Partner for Digital Health Companies in Oncology?

Digital health in oncology is still a very raw and undefined practice with companies still searching for a best approach to put these solutions into the patients' hands. Join this peer-to-peer conversation to deep dive into this discussion.

Eoin Tabb
Featuring
Eoin Tabb
A/ Chief II Pharmacist, Cancer Services, HSE
Clinical Trials Innovation
1st February @ 11AM EDT

HealthXL Webinar: The Potential of AI in Drug Discovery

The drug discovery process has traditionally been costly and very time-consuming. Join this Webinar to deep dive into this topic with senior leaders in this area.

Armen Vidian
Featuring
Armen Vidian
Digital Health Venture Capitalist
Digital Therapeutics (DTx)
1st February @ 10AM GMT / 6PM AWST

Masterclass: How to Navigate the NHS Digital Technology Assessment Criteria and NICE evidence guidelines

Are you trying to increase adoption and use of your Digital Health solution across the UK's National Health Service? Join your peers in this meeting as they deep dive into this topic. Apply now to secure your place as seats are limited.

Richard Bunney
Featuring
Richard Bunney
Director, Cuniculo Ltd
Telemedicine & Virtual Care Delivery
2nd February @ 10:45AM EDT

Masterclass: How to Make Value-Based Health Care (VBHC) work with Digital Health?

Would you like to learn more about value-based health care models (VBHC) and the interplay between these systems and digital health solutions? Join HealthXL in this Masterclass led by Matt Hickey to deep dive into this topic. Seats are limited so apply now to secure your place.

Matt Hickey
Featuring
Matt Hickey
CEO, The Health Value Alliance
16th February @ 11AM EDT

Executive 1-2-1 with the HealthXL Digital Health Community

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for this new HealthXL style of virtual speed networking and meet other members working in this space!

Steven Peretz
Featuring
Steven Peretz
Group Director, Health Experience & Product Strategy, Appnovation
Digital Therapeutics (DTx)
7th December @ 10:45AM EDT

DTx-Drug Combination Therapy: What Should the Trial Look Like?

DTx-Drug combinations can improve the treatment value, thus leading to better patient outcomes. Join HealthXL in this session to discuss this topic with thought leaders in this space.

Myles Furnace
Featuring
Myles Furnace
Commercial VP, Closed Loop Medicine
Digital Therapeutics (DTx)
6th December @ 10:45AM EDT

Sprint: Pharma Sales Model for DTx-Drug Combination (Part 1)

While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. Join this 2 part sprint to establish 5 key challenges and agree on 5 key recommendations to overcome them with your peers working in this space.

John Cairns
Featuring
John Cairns
Global Head of Digital, Oncology Franchise, Sanofi
Digital Therapeutics (DTx)
30th November @ 10:45AM EDT

Sprint: Conditions Needed for Pharma to Launch Standalone DTx (Part 2)

Unarguably, DTx solutions have clear benefits for patients. Join HealthXL in this 2 part meeting to establish 5 key challenges and agree on 5 key recommendation to overcome them.



Malin Johansson
Featuring
Malin Johansson
Global Head of Digital Health Partnerships at Novo Nordisk
Digital Therapeutics (DTx)
30th November @ 10:00AM GMT / 6:00PM AWST

Masterclass: The New Reimbursement Pathway in France

The reimbursement path for digital health solutions in Europe has always been complex to navigate. Join this Masterclass led by Aymeric Perchant to deep dive into this topic.

Aymeric Perchant
Featuring
Aymeric Perchant
eHealth Projects Director, French Ministry of Health/Ministère des solidarités et de la santé
Digital Health in Oncology
29th November @ 10:45AM EDT

Incentives and Standards for Robust Evidence from Digital Health in Oncology

Due to the lack of industry-wide evidence frameworks for digital health solutions in oncology, regulators' and payers' requirements are usually the same as drugs. Join HealthXL in this meeting to deep dive into this topic.

Simon Spahrkäs
Featuring
Simon Spahrkäs
Head of Research, Tired of Cancer
Digital Therapeutics (DTx)
29th November @ 10:45AM EDT

Roadmap Execution in a Pharma-DTx Partnership

While the number of partnerships between DTx and Pharma have grown in the past years, we haven’t seen big successes yet, and part of that could be due to bad roadmap definition and its execution. Join your peers in this meeting to discuss this topic further


Till Bauer
Featuring
Till Bauer
Global Oncology LCM Strategy Director at MSD
23rd November @ 10:45AM EDT

Innovation Showcase: Digital Health for Chronic Kidney Disease (CKD)

In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.

Mark Grossman
Featuring
Mark Grossman
VP Growth Strategies , GoMo Health
Digital Mental Health & Neurology
22nd November @ 10:45AM EDT

Building Incentive Models for Digital Health in Neurodegenerative Diseases

In Neurodegenerative Diseases, aging is a risk factor and as the older populations grow, its prevalence increases, leading to an enormous burden on healthcare systems. Join this meeting to deep dive into this topic with other senior leaders in this field.

Adam Cohen
Featuring
Adam Cohen
Chief Scientist, Johns Hopkins University
Digital Health in Oncology
21st November @ 10:45AM EDT

Adoption Beyond Reimbursement for Digital Health in Oncology

Are you struggling to get patients and healthcare professionals (HCPs) to adopt your digital health product? Join this meeting to deep dive into this topic with your peers working in this space.

Adam Pellegrini
Featuring
Adam Pellegrini
CEO & Co-Founder, Jasper Health
Telemedicine & Virtual Care Delivery
17th November @ 11:00AM EDT

HealthXL Webinar: Metaverse in Healthcare

Join us for our next HealthXL Webinar 'Metaverse in Healthcare' where we will take a deeper look at the potential the metaverse has in the healthcare space.

Kellee Franklin
Featuring
Kellee Franklin
Founder, Mindful Innovation Labs
Digital Health in Oncology
15th November @ 10:45AM EDT

Integrating Oncology Digital Health with Health Systems Workflows

Oncology services have changed in recent years from the way cancer is diagnosed to how treatment is being delivered. Join other senior leaders in this session to deep dive into this topic.

Anthony Cunliffe
Featuring
Anthony Cunliffe
Oncology Lead, ORCHA
Digital Therapeutics (DTx)
10th November @10:45AM EDT

Masterclass: Endpoints Selection in Clinical Trials for Digital Health Solutions

Proving clinical efficacy is one of the biggest challenges for SaMD manufacturers. However, it is key to getting buy-in from stakeholders. Join this Masterclass led by Shaheen Lakhan (Chief Medical Officer, Click Therapeutics) to depp dive into this topic with other senior leaders in this area.

Shaheen Lakhan
Featuring
Shaheen Lakhan
Chief Medical Officer , Click Therapeutics
Digital Therapeutics (DTx)
9th November @ 10:45AM EDT

Sprint: Conditions Needed for Pharma to Launch Standalone DTx (Part 1)

Unarguably, DTx solutions have clear benefits for patients. Join HealthXL in this 2 part Sprint where we will break this topic down into 5 key challenges and agre on 5 key recommendations to overcome the challenges.

Malin Johansson
Featuring
Malin Johansson
Global Head of Digital Health Partnerships at Novo Nordisk
Telemedicine & Virtual Care Delivery
9th November @ 10:45AM EDT

Big Tech and Digital Health

There is no question that Big Tech has the capability to disrupt healthcare, though the complexity of healthcare ecosystems is not making it easy for these companies. Join this meeting to dive deeper into this topic and discuss how Big Tech is getting into digital health.

Jo Peddhinti
Featuring
Jo Peddhinti
Director, Digital Health Advisory, HealthXL
Digital Therapeutics (DTx)
8th November @ 10:45AM EDT

Building a Value Proposition that Addresses Payers Pain Points

Many DTx companies target payers to get reimbursed, but very few vendors get what they are looking for. Join this meeting to deep dive into this topic with other senior leaders in this area.

Michael Pace
Featuring
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
8th November @ 10:45AM EDT

How Can DTx Companies Monetize the RWD They Generate?

Real-World Data (RWD) can be highly valuable for many stakeholders in healthcare, such as pharma, MedTech, payers, or hospitals. Join this Masterclass, led by Philip Russmeyer (Founder, FITFILE) to discuss this topic further.

Philip Russmeyer
Featuring
Philip Russmeyer
Founder & CEO, FITFILE
Telemedicine & Virtual Care Delivery
3rd November @ 11:45AM EDT

Digital Health for the Prediction of Cardiovascular Events

Cardiovascular diseases (CVD) have been at the forefront of digital health innovations. Join HealthXL in this meeting where we will focus on the use of digital health tools for the prediction of cardiovascular events.

Tom Wilkinson
Featuring
Tom Wilkinson
Chief Science Officer and Co-Founder, My MHealth
Digital Therapeutics (DTx)
3rd November @ 11:45AM EDT

Physician Adoption of Prescription DTx

Physician adoption is one of the keys to unlocking the revenues expected from DTx solutions. Join HealthXL in this meeting to discuss this topic with other senior leaders in this field.

Kal Patel
Featuring
Kal Patel
CEO & Co-Founder at BrightInsight
Digital Therapeutics (DTx)
2nd November @ 10AM GMT / 6PM AWST

Masterclass: Navigating the DiGA Framework: a Case Study

Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Join us in this interactive masterclass led by Dr. Victor Stephani (responsible for Market Access and Chief of Staff at HelloBetter) to discuss this topic further.

Dr. Victor Stephani
Featuring
Dr. Victor Stephani
Chief of Staff, HelloBetter
Digital Mental Health & Neurology
27th October @ 10:45AM EDT

Innovation showcase: Digital Biomarkers in Neurology

In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Biomarkers partners to discuss mutual challenges they face when building successful collaborations. Seats are limited so apply now to join this session.

Mansa Shroff
Featuring
Mansa Shroff
Head of Partnerships at WKD.SMRT
Digital Health in Oncology
27th October @ 10:45AM EDT

Partnerships between Oncology Digital Health and Life Sciences Companies

In a complex disease area like oncology, treatments usually cause adverse effects that compromise patients' quality of life. Join this session to discuss this topic further with your peers working in this field.

Till Bauer
Featuring
Till Bauer
Global Oncology LCM Strategy Director at MSD
Telemedicine & Virtual Care Delivery
26th October @ 10:45AM EDT

Sprint: Integrating RPM into Health Systems and Hospital Workflows (Part 2)

While integrating Remote Patient Monitoring programs (RPM) into health systems and hospital workflows is key to push the adoption rates, it is not an easy task. Join Part 2 of this sprint where we will continue this discussion and break this down into 5 key challenges and agree on 5 key recommendations to overcome them.

Sarah Carroll
Featuring
Sarah Carroll
Vice President, AVIA
Digital Therapeutics (DTx)
26th October @ 10AM GMT/ 5PM AWST

How to Sell DTx to Life Sciences Companies?

Over the last few years, partnerships between digital therapeutics (DTx) and Life Sciences companies have grown exponentially. Join HealthXL in this meeting to discuss this topic with thought leaders in this area.

Aahuti Rai
Featuring
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Digital Health in Oncology
25th October @ 10:45AM EDT

Outcome Measures in Oncology Digital Health Interventions: What and How to Measure?

Digital health solutions can track a huge amount of data points, but tracking too many different measures can make you lose focus. Join HealthXL in this meeting to discuss this with other thought leaders working in this area.

Hassan Naqvi
Featuring
Hassan Naqvi
Lead, External Alliances and Digital Partnerships at AstraZeneca
Clinical Trials Innovation
24th October @ 10:45AM EDT

Innovation Showcase: Digital Health Solutions for Decentralized Clinical Trials

In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Apply now to book your place in this bilateral discussion.



Steffanie Bristol
Featuring
Steffanie Bristol
Head, Biogen Digital Health External Innovation and Alliances, Imaging & AI/ML, Biogen
Digital Health Meeting
20th October @ 10:45AM EDT

The Drop in DTx Investments: What are the implications

When the pandemic was hitting the world, venture capitalists invested more than ever in Digital Therapeutics (DTx) as the world was moving away from the traditional in-person care settings, and patients needed new ways to access care and treatments. Join HealthXL to discuss this topic with your peers working in this area.



Edward Kliphuis
Featuring
Edward Kliphuis
Partner, Sofinnova Partners
Digital Therapeutics (DTx)
19th October @ 10AM GMT/5PM AWST

Success Metrics of Patient Engagement with DTx Solutions

In a world where customers are used to excellent user experience (e.g. Google, Amazon, Apple, etc.), DTx companies need to meet customers' expectations. Join other senior leaders in this session to discuss what the success metrics of patient engagement are for DTx solutions.

Aahuti Rai
Featuring
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Clinical Trials Innovation
18th October @ 10:45AM EDT

Masterclass: Clinical Trial Design Considerations for Prescription Digital Therapeutics and Therapeutic Digital Health Products

Are you considering clinical validation for a SaMD or SaMD/PDT+drug combination product? Join this meeting to discuss this topic further with others working in this field

Yuri Maricich MD MBA
Featuring
Yuri Maricich MD MBA
Chief Medical Officer & Head of Development, Pear Therapeutics
Digital Therapeutics (DTx)
18th October @ 10:45AM EDT

Combined Label Claims for Drug + DTx Combinations

As more DTx-drug combinations emerge, regulation is becoming increasingly important. Join HealthXL in this meeting to dive deeper into this topic.



Zina Manji
Featuring
Zina Manji
Sr Director of Regulatory Affairs at GSK
Clinical Trials Innovation
13th October @ 10:45AM EDT

The Use of New Technologies to Improve Clinical Trial Operational Efficiency

Clinical trials are thoughtfully designed and implemented to ensure the right patients are involved, quality standards are strictly followed, and the endpoints selected are the right ones to show the drug’s safety and effectiveness. Join HealthXL in this discussion to dive deeper into this topic.



Matt Wilson
Featuring
Matt Wilson
CEO, uMed
Digital Mental Health & Neurology
13th October @ 10:45AM EDT

Partner Search and Selection for Digital Health Companies in Mental Health

Digital solutions have great potential in mental health, improving care access, symptom tracking, and treatment personalization. Join HealthXL in this meeting to discuss this topic further with your peers working in this area.


Mimi Winsberg, M.D.
Featuring
Mimi Winsberg, M.D.
Chief Medical Officer and Co-Founder, Brightside Health
Telemedicine & Virtual Care Delivery
12th October @ 10:45AM EDT

Sprint: Integrating RPM into Health Systems and Hospital Workflows (Part 1)

While integrating Remote Patient Monitoring programs (RPM) into health systems and hospital workflows is key to push the adoption rates, it is not an easy task. Join this two part session to discuss this topic further.

Sarah Carroll
Featuring
Sarah Carroll
Vice President, AVIA
Digital Health in Oncology
12th October @ 10:45AM EDT

Adoption Beyond Reimbursement for Digital Health in Oncology

Are you struggling to get patients and healthcare professionals (HCPs) to adopt your digital health product? Join HealthXL in this meeting to discuss this further.



Adam Pellegrini
Featuring
Adam Pellegrini
CEO & Co-Founder, Jasper Health
11th October @ 11:15AM EDT

Masterclass: The Essentials of Working with the FDA for the Approval of AI-based Solutions

Join this masterclass led by Tahir Rizvi (Head of Quality Assurance and Regulatory Affairs at Caption Health) and Armen Vidian (Digital Health Venture Capitalist) to learn more about the regulatory considerations for AI-based solutions in the US.

Armen Vidian
Featuring
Armen Vidian
Digital Health Venture Capitalist
Digital Therapeutics (DTx)
10th October @ 10:45AM EDT

Masterclass: DTx Reimbursement in the US: Government-sponsored plans (Medicaid and Medicare)

Are you a digital therapeutics (DTx) company seeking reimbursement in the US market? Join this masterclass led by the biopharma and DTx reimbursement expert Mike Pace to dive deeper into this topic.

Michael Pace
Featuring
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
6th October @ 10:45AM EDT

Masterclass: Investments in Digital Health: The Art of Storytelling

Are you a digital health company looking to fundraise, acquire new customers or hire key executives? If so, crafting a story that inspires, builds trust, and drives credibility is critical. 

Robert Garber
Featuring
Robert Garber
Partner, 7wireVentures
6th October @ 11AM EDT

Executive 1-2-1 with the HealthXL Digital Health Community

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!



Ashley Pippin
Featuring
Ashley Pippin
Director, Digital Product Delivery, Novartis Biome
5th October @ 11:00AM EDT

HealthXL Webinar: The Unique Opportunities and Challenges of Digital Health in Rare Disease

In this webinar with Ankita Deshpande (Head of Innovation Accelerator at Alexion Pharmaceuticals), we will deep dive into the unique opportunities and challenges of digital health in rare diseases. Register now to secure your place!

Ankita Deshpande
Featuring
Ankita Deshpande
Head of Innovation Accelerator, Alexion Pharmaceuticals
Digital Therapeutics (DTx)
4th October @ 10:45AM EDT

What are the Best Business Models for DTx in the US?

What are the best models for DTx in the US in this new reality? How will the business models change in the future? Join us in a peer-to-peer conversation where we will discuss these questions and more!

Kal Patel
Featuring
Kal Patel
CEO & Co-Founder at BrightInsight
Telemedicine & Virtual Care Delivery
3rd October @ 10:45AM EDT

Masterclass: Human-Centric Design for Digital Health Solutions

Healthcare is one of those areas that one would expect to be more human-centric, at the end of the day, what is more human than getting sick? Join HelathXL in this masterclass led by Kellee M. Franklin, PhD, Founder of Mindful Innovation Labs, and Carole Tremonti, VP Clinical Strategy at Project Cronin, where they will discuss how we can be more human-centric when creating digital health solutions for patients and the care team.

Kellee M. Franklin, PhD
Featuring
Kellee M. Franklin, PhD
Founder | Mindful Innovator, Mindful Innovation Labs
Digital Therapeutics (DTx)
28th September @ 10AM GMT / 5PM AWST

Are Pharma Partnerships the Wrong Strategy for DTx Companies?

While the digital therapeutics (DTx) market is increasingly growing, it is still small compared to large players in the healthcare industry such as pharma. Join HealthXL in this peer-to-peer discussion to deep dive into this topic.

Eugene Borukhovich
Featuring
Eugene Borukhovich
COO & Co-Founder of YourCoach.Health
Telemedicine & Virtual Care Delivery
28th September @ 10:45AM EDT

What Will the Best Business Models Be for Virtual Care in Diabetes?

Join this meeting to take a deep dive into what the best business models will be in the next few years for virtual care companies in the diabetes space.

Frank Westermann
Featuring
Frank Westermann
Co-Founder & Co-CEO, 9am.health
Digital Therapeutics (DTx)
27th September @ 10:45AM EDT

Masterclass: Translating European Regulatory Guides into Practical Steps for DTx Solutions

Are you trying to commercialize a digital therapeutics (DTx) solution in the European Union (EU)? Would you like to learn practical steps on how to navigate the European regulatory landscape? Keep reading, this masterclass is for you!

Stephen Gibney
Featuring
Stephen Gibney
Quality Director, BlueBridge Technologies
Digital Therapeutics (DTx)
27th September @ 10AM GMT/5PM AWST

Masterclass: The New Reimbursement Path for Digital Health in Belgium

The right commercialization model for a digital health product is a key component of success in this rapidly growing space. Join this masterclass led by Steven Vandeput, PhD, to discuss this topic further.

Steven Vandeput, PhD
Featuring
Steven Vandeput, PhD
Advisor Extramuros & Digital Health, beMedTech
Digital Therapeutics (DTx)
26th September @ 10:45AM EDT

If DTx Companies Operated like Pharma, What Would We Have?

Pharma companies are huge corporations with complex operations to ensure the quality of their products and services. Join HealthXL in this meeting to deep dive into this topic with others working in this space.

Anish Shindore
Featuring
Anish Shindore
Founder & Managing Partner, GSD Health
Telemedicine & Virtual Care Delivery
20th September @ 10:45AM EDT

Pharma Partnerships with Virtual Care Companies

The accelerated growth of the virtual care industry since the pandemic has opened many opportunities for virtual care companies. Join HealthXL in this meeting to dive deeper into this topic and discuss further with your peers working in this space.

Dirk Schroeder
Featuring
Dirk Schroeder
Chief Strategy Officer, Shepherd
Digital Therapeutics (DTx)
19th September @ 10:45AM EDT

Are DTx a Service or a Product?

Digital therapeutics (DTx) and drugs are very different care solutions. However, DTx are often compared to traditional pharmaceutical products because the terminology and definitions are unclear. Join this meeting to discuss this topic further with your peers.



Edward Kliphuis
Featuring
Edward Kliphuis
Partner, Sofinnova Partners
Digital Health in Oncology
19th September @ 10AM GMT/5PM AWST

Do’s and Don’ts when Seeking Partnerships for Digital Health in Oncology

Most digital health companies in oncology will struggle to get their products in the market on their own. Join HealthXL in this meeting to discuss the do's and don'ts when seeking partnerships for digital health companies in oncology.

Gandolf Finke
Featuring
Gandolf Finke
Founder & MD at Mika/Fosanis GmbH
15th September @ 11AM EDT

Executive 1-2-1 with the HealthXL Digital Health Community

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!



Nemanja Kovačev
Featuring
Nemanja Kovačev
MedTech Expert, HTEC Group
Digital Therapeutics (DTx)
15th September @ 10:45AM EDT

New Distribution Channels for DTx

Are you trying to figure out what is the best distribution channel for your digital therapeutics (DTx) solution? Join this meeting to discuss this topic further with your peers working in this space.

Timothy Aungst
Featuring
Timothy Aungst
Associate Professor of Pharmacy Practice, MCPHS University, The Digital Apothecary
Digital Mental Health & Neurology
14th September @ 10:45AM EDT

Sustainable Business Models for Digital Health in Neurology

Digital health companies can take different routes to market, however, finding the one that is sustainable and scalable in the long term, is not an easy task. Join this meeting to discuss this topic further with others working in this space.

Ciara Clancy
Featuring
Ciara Clancy
Founder & CEO, Beats Medical Ltd
Digital Mental Health & Neurology
14th September @ 11.30AM EDT

HealthXL Webinar with Russell Glass: Business Models for Digital Companies in the Mental Health Space

What makes for a successful business model for digital companies in mental health? Join us in this fireside chat with Russell Glass, CEO at Headspace Health, where we will deep dive into the business models for digital companies in the mental health space. Register now to secure your place.

Russell Glass
Featuring
Russell Glass
CEO at Headspace Health
Digital Therapeutics (DTx)
12th September @ 10:45AM EDT

Evidence Requirements for DTx vs Drugs

Are you targeting payers as part of your market access strategy? What do you need to know about their evidence requirements for DTx? Join HealthXL in this meeting to discuss this topic further with your peers working in this space.

Jordan Silberman, MD, PhD
Featuring
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Digital Therapeutics (DTx)
12th September @ 10:45AM EDT

Seeking Capital for DTx

Are you a digital therapeutics (DTx) start-up seeking capital? How can companies get attention from investors in an increasingly competitive industry? Join HealthXL in this meeting to discuss this topic further with others working in this space.

Will Gibbs
Featuring
Will Gibbs
Principal at Octopus Ventures
Digital Therapeutics (DTx)
8th September @ 10:45AM EDT

DTx Evidence Generation: What can we learn from the Pharma and Medical Device Industries?

The definition of Digital Therapeutics (DTx) is broad, including many different solutions, making it hard to agree on the evidence generation standards. Join this meeting to dive deeper into this topic and learn from your peers working in this area.

 Luis Fernandez-Luque
Featuring
Luis Fernandez-Luque
Chief Scientific Officer, Adhera Health
Digital Therapeutics (DTx)
7th September @ 10:45AM EDT

Masterclass: Regulation of DTx in the US - Experience from a Real Company

Are you trying to get your DTx solution regulated in the US? Would you like to learn from the experiences of a real company? Join HealthXL in this masterclass led by Michelle Rubin-Onur from Blue Note Therapeutics to dive deeper into this topic

Michelle Rubin-Onur
Featuring
Michelle Rubin-Onur
Director of Regulatory, Blue Note Therapeutics
Webinar
31st August @ 11:00AM EDT

HealthXL Webinar with Julie Murchinson: Growth and Scalability Strategies in Digital Health

The investment case for digital health solutions is straightforward in many therapeutic areas, such as diabetes, oncology, mental health, women’s health, among others.

Join HealthXL's next webinar with Julie Murchinson, Partner at Transformation Capital, as we discuss growth and scalability strategies in digital health. Apply now to secure your place.

Julie Murchinson
Featuring
Julie Murchinson
Partner, Transformation Capital
Clinical Trials Innovation
31st August @ 10:45AM EDT

Incorporating Digital Measurement Technologies in Clinical Trials: Challenges & Best Practices

Are you working on incorporating digital measurement technologies into clinical trials?
Shwen Gwee
Featuring
Shwen Gwee
Former VP and Head of Global Digital Strategy at Bristol Myers Squibb
Telemedicine & Virtual Care Delivery
29th August @ 10:45AM EDT

Innovation Showcase: Digital Health for Cardiometabolic Diseases

In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Apply now to book you place in this meeting.

Stephen Egan
Featuring
Stephen Egan
Director, Redicare
Digital Therapeutics (DTx)
25th August @ 10:45AM EDT

Sprint: How to Overcome the Blockers to DTx Adoption and Measure Success? (Part 2)

While new legislations and rules (such as DiGA in Germany) have opened new options for reimbursement, adoption of digital therapeutics (DTx) remains insufficient to achieve the revenue expected from these solutions. Join this 2 part sprint to discuss this topic further.

Mette Dyhrberg
Featuring
Mette Dyhrberg
Founder & CEO, Mymee
Digital Mental Health & Neurology
24th August @ 10:45AM EDT

Innovation Showcase: Digital Health Solutions for Depression & Anxiety

In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Apply now to book your place in this event.

Jeff Weness
Featuring
Jeff Weness
Head of Digital Opportunities and Business Intelligence at Otsuka
Digital Health in Oncology
23rd August @ 10:45AM EDT

Incentive Models for HCP & Care Team to Adopt Digital Health in Oncology

What are the best incentive models to encourage health care professionals (HCPs) and care teams to adopt digital health in oncology? Join this meeting to discuss this topic further with others working in this space.

Susan Bratton
Featuring
Susan Bratton
CEO & Founder at Savor Health
Digital Therapeutics (DTx)
17th August @ 10:45AM EDT

Payers Partnerships for DTx

Digital Therapeutics (DTx) vendors face many challenges on their journey to commercialization, such as generating clinical data, health economics evidence and achieving regulatory status. Join this meeting to discuss this topic further and share your experiences with others working in this space.

Elena Mustatea
Featuring
Elena Mustatea
CEO, Bold Health
Digital Therapeutics (DTx)
16th August @ 10:45AM EDT

Sustainable Business Models for DTx

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Elena Mustatea
Featuring
Elena Mustatea
CEO, Bold Health
15th August @11AM EDT

Executive 1-2-1 with the HealthXL Digital Health Community

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Aahuti Rai
Featuring
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Digital Therapeutics (DTx)
11th August @ 10:45AM EDT

Masterclass: Value, Cost and Pricing in Regulated Digital Health Solutions

Digital Health solutions are top of mind for biopharma companies in 2022, and Software as Medical Device (SaMD) is a crucial cornerstone for top-tier companies. Join this Masterclass led by BrightInsight to dive deeper into this topic and discuss this further with your peers working in this space.

David Matthews, PhD
Featuring
David Matthews, PhD
CCO, BrightInsight
Digital Therapeutics (DTx)
10th August @ 10:45AM EDT

Masterclass: DTx Reimbursement in the US - PBMs as Coverage Scale Catalysts

Are you a DTx or Pharma company seeking wide-spread reimbursement of a DTx product in the US? Join this Masterclass led by Mike Pace to learn more about this topic and share your experiences with others working in this space.

Michael Pace
Featuring
Michael Pace
CEO & Founder at PalmHealth.co
Telemedicine & Virtual Care Delivery
9th August @ 10:45AM EDT

Getting Virtual Care Solutions into the Physician’s and Care Team’s Workflows

With the pandemic, we saw a rapid expansion of telemedicine and remote patient monitoring (RPM) solutions as a new way of delivering healthcare. Join HealthXL in this meeting to discuss this topic further with others working in this space.

Lee Shapiro
Featuring
Lee Shapiro
Managing Partner, 7wireVentures
Digital Health in Oncology
3rd August @ 10:45AM EDT

Scalable Business Models for Digital Health in Oncology

The investment case for digital health and oncology is straightforward - apply digital innovation to one of the most prevalent diseases worldwide, improve millions of patients' lives, and reap the rewards. Join your peers in this meeting to dive deeper into this topic.

Lynda Chin
Featuring
Lynda Chin
Founder, President and CEO, Apricity Health
Digital Therapeutics (DTx)
28th July @ 10:45AM EDT

Evidence Generation for Standalone DTx

Standalone digital therapeutics (DTx) solutions are not comparable to drugs or standard treatment protocols. Join this meeting to dive deeper into this topic with others working in this space.

Ciara Clancy
Featuring
Ciara Clancy
Founder & CEO, Beats Medical Ltd
Digital Therapeutics (DTx)
26th July @ 10:45AM EDT

Masterclass: The Regulation of DTx in the US

How to successfully take a DTx product through the regulatory pathways in the US? Join this Masterclass led by Jason Brooke, medical device attorney and regulatory/quality advisor, as we dive deeper into this topic.

Jason Brooke
Featuring
Jason Brooke
Attorney & Managing Member, Brooke Consulting, LLC
Digital Health in Oncology
26th July @ 10AM EDT

HealthXL Webinar with Cristina Ortega Duran: Digital Health in Pharma R&D for Oncology

Join our next HealthXL Webinar with Cristina Duran, Chief Digital Health Officer R&D at AstraZeneca, as we discuss Digital Health in Oncology. Register now to secure your place!

Cristina Duran
Featuring
Cristina Duran
Chief Digital Health Officer, AstraZeneca
Telemedicine & Virtual Care Delivery
21st July @ 10:45AM EDT

Masterclass: An Amazon like Customer Experience: Tips & Tricks for Pharma

Spotify, Disney, Amazon, what do all of these organizations have in common? Top class customer experience. Join this Masterclass led by Sutherland to learn more about successful customer experience strategies and how pharma and medtech companies can improve their customers' experience.

Matthew Collier
Featuring
Matthew Collier
Chief Executive Officer, Sutherland Healthcare Solutions
Digital Therapeutics (DTx)
21st July @ 10:45 AM EDT

Partnership Roadmap for Pharma - DTx Collaborations

What is the partnership roadmap for pharma and digital therapeutics (DTx) companies collaborations? Join your peers working in this space to learn more about this topic and share your experiences.

Francesca Wuttke
Featuring
Francesca Wuttke
CEO and Founder, nen Health
21st July @ 11:00AM EDT

Executive 1-2-1 with the HealthXL Digital Health Community

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Daniela Delforio
Featuring
Daniela Delforio
Founder and Principal Consultant at Dadal Consulting Ltd
Digital Mental Health & Neurology
20th July @ 10:45AM EDT

Sprint: DTx in Mental Health: Partnerships with Pharma (Part 2)

What makes for a successful partnership? While the value of DTx within mental health is being recognized, getting to commercialization and adoption remains a challenge.
Myles Furnace
Featuring
Myles Furnace
Commercial VP, Closed Loop Medicine
Digital Health in Oncology
19th July @ 10:45AM EDT

Masterclass: Investing In Oncology - Digital Pathology and Real World Evidence and Data

How can we leverage technological advancements to drive an explosive evolution in pathology? Join this Masterclass led by Bill Taranto to dive deeper into this topic.

Bill Taranto
Featuring
Bill Taranto
President, Merck Global Health Innovation Fund
Digital Therapeutics (DTx)
14th July @ 10:45AM EDT

What Label Claims can you make about your DTx?

As the Digital Therapeutics (DTx) industry matures, regulation is becoming increasingly important. Join this meeting to share your experiences with others working in this space.

Anish Shindore
Featuring
Anish Shindore
Founder & Managing Partner, GSD Health
Clinical Trials Innovation
13th July @ 10:45AM EDT

Masterclass: Clinical Trial Design for Digital Health Products

How can we design trials for our digital health tools so they are rigorously validated and regulated? Join this Masterclass led my Akili Interactive to learn more about this topic.

Vandana Menon
Featuring
Vandana Menon
VP, Clinical Research & Evidence Generation at Akili Interactive
Digital Mental Health & Neurology
12th July @ 10:45AM EDT

DTx in Mental Health: Building Clinical & Economic Evidence

Within digital therapeutics (DTx), mental health is an area showing major potential, particularly given that drug compliance tends to be a considerable problem and pharmacological treatments are usually not enough to get the desired outcomes. Join this meeting to dive deeper into this topic and share your experiences with others in the field.

Marie Atallah, PhD
Featuring
Marie Atallah, PhD
Clinical communications lead, Big Health
Telemedicine & Virtual Care Delivery
11th July @11AM EDT

Executive 1-2-1 to Discuss Virtual Care Adoption Challenges

A company might be able to create excellent virtual care solutions, but it won't have much of an impact if no one uses them. Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Richie Bavasso
Featuring
Richie Bavasso
Co-Founder, nQ Medical
Digital Health in Oncology
11th July @ 10:45AM EDT

Oncology Digital Health: Evidence Requirements from Payers and Regulatory Bodies

The marriage of digital health and oncology is very new, with companies still figuring out the best approach to establish in the market. Join this meeting to discuss this topic further with others working in this field.

Andrew Norden
Featuring
Andrew Norden
Chief Medical Officer, OncoHealth
Digital Therapeutics (DTx)
7th July @ 10AM GMT/ 5PM AWST

Masterclass: Reimbursement of Digital Health in Europe - the DiGA framework

Regulatory clearance and the best commercialization model for a digital health product are among the key components for success in a rapidly growing sector. Join this Masterclass led by Flying Health to dive deeper into this topic.

Laura Nelde
Featuring
Laura Nelde
Startup Relationship Manager at Flying Health
Telemedicine & Virtual Care Delivery
7th July @ 10:45AM EDT

Digital Health for Immune-Mediated Inflammatory Conditions

Millions of people worldwide suffer from immune-mediated, inflammatory conditions (IMIDs) such as rheumatoid arthritis, atopic dermatitis, psoriasis, ulcerative Colitis, and multiple sclerosis, to name a few. Join this meeting to discuss this and share your experiences with others working in this space.

Nader Alaghband
Featuring
Nader Alaghband
Founder at Ampersand Health
Digital Therapeutics (DTx)
30th June @ 10:45AM EDT

Sustainable Business Models for DTx in the US

Cracking the US market is no mean feat for digital health companies.
Rick Bartels
Featuring
Rick Bartels
Managing Partner , DTxCC
Telemedicine & Virtual Care Delivery
29th June @ 10:45AM EDT

What’s in Remote Patient Monitoring Programs for Pharma?

As the Covid-19 pandemic shifted how people interact with healthcare, the relationship between pharma and patients changed as many moved away from conventional clinical settings. Join this meeting to discuss this topic further and share your thoughts and experiences with your peers.

Brian Flatley
Featuring
Brian Flatley
VP Consulting Services at S3 Connected Health
Digital Health in Oncology
28th June @ 10:45AM EDT

Innovation Showcase: Digital Patient Support Programs (PSPs) in Oncology

Are you a Digital Health company, Pharma executive, Medtech executive, or Venture Capitalist (VC), working in Patient Support Programs (PSPs) in oncology and seeking guidance to build successful partnerships? Then keep reading, this meeting is for you

Fiona Clemente
Featuring
Fiona Clemente
Digital Health Scouting Officer, WeHealth
Digital Therapeutics (DTx)
27th June @ 10:45AM EDT

DTx-Generated RWD: What is the Value for Pharma?

Real-world data (RWD) can be highly valuable to pharma companies; with several use cases from drug discovery and development to drug market access, label extensions, and understanding how their drugs and competitors are used in real life. Join this meeting to discuss this topic further with others working in this space.

Myles Furnace
Featuring
Myles Furnace
Commercial VP, Closed Loop Medicine
Digital Therapeutics (DTx)
23rd June @ 10:45AM EDT

The DTx Opportunity for Pharma Companies

While the relationship between digital therapeutics (DTx) and pharma is still in its infancy, we are seeing the emergence of some compelling models and partnerships that illustrate the opportunities in the market. Join HealthXL in this meeting to dive deeper into this topic.

Omri Shor
Featuring
Omri Shor
Founder & CEO at Medisafe® Medication Adherence Platform
Digital Therapeutics (DTx)
22nd June @ 10:45AM EDT

Telehealth Platforms as a Distribution Channel for DTx and RPM Products

As the digital health industry grows exponentially, patients and providers are being flooded by hundreds of digital health products. Join this meeting to share your experiences and learn from others working in this space.

Anish Shindore
Featuring
Anish Shindore
Founder & Managing Partner, GSD Health
Clinical Trials Innovation
21st June @ 10:45AM EDT

Masterclass: How to Design a Clinical Trial for your Digital Health Product?

Are you struggling with trial design for your digital health products? Join this meeting to discuss this further with others working in this space.

Efren Rael
Featuring
Efren Rael
Senior Medical Director, Clinical Affairs, Biofourmis
Digital Therapeutics (DTx)
21st June @ 3PM AWST / 8AM GMT

Masterclass: The Regulation of SaMD in the EU

Are you trying to get your SaMD product regulated in the European Union (EU)? Join HelathXL in this meeting to discuss this topic further with others working in this space.

Padraig Maguire
Featuring
Padraig Maguire
Head of Quality & Regulatory Affairs at S3 Connected Health
Digital Therapeutics (DTx)
20th June @ 11:00AM EDT

HealthXL Virtual Networking Event - Digital Therapeutics Community

Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Randy Horton
Featuring
Randy Horton
VP of Solutions and Partnerships, Orthogonal
Clinical Trials Innovation
20th June @ 10:45AM EDT

Digital Biomarkers in Clinical Trials: Do’s & Don’ts in the Validation Process

Novel digital biomarkers have the potential to be part of clinical trials, but there are still a lot of questions regarding their reliability and validation process. Join this meeting to discuss this topic further with your peers in the field.

Doina Sirbu
Featuring
Doina Sirbu
Medical Device Innovation Lead, UCB
Digital Health in Oncology
16th June @ 10:45 AM EDT

Sprint: Virtual Care in Oncology: HCP and Patient Adoption

Are you struggling with getting HCPs and patients to adopt your digital health solution in oncology? Apply now to join this series of two meetings to discuss this topic further and learn from your peers.

Carole Tremonti
Featuring
Carole Tremonti
VP Operations & Strategy, SimBioSys
Digital Therapeutics (DTx)
15th June @ 10:00AM EDT

HealthXL Webinar with Robert Garber: How to get Funding for a Digital Health Solution

Join our upcoming webinar with Robert Garber from 7wireVentures as we discuss how to get funding for a digital health solution.



Robert Garber
Featuring
Robert Garber
Partner, 7wireVentures
Digital Therapeutics (DTx)
14th June @ 10:45AM EDT

Masterclass: DTx Reimbursement in the US - Value-Based Contracting Basics

Are you a DTx or Pharma company seeking coverage of your DTx in the US market? How should we be thinking about value-based agreements (VBA) in the context of DTx reimbursement in the US? Join this masterclass led by biopharma and PDT outcomes-based contracting pioneer, Mike Pace, to dive deeper into this topic.

Michael Pace
Featuring
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
13th June @ 10:45AM EDT

Combo DTx-drug: Pharma Opportunities

DTx-drug combinations (‘combo’) are becoming one of the easiest ways for digital therapeutics (DTx) companies to commercialize their products through pharma. Join this meeting to discuss this topic with others working in the Digital Therapeutics space.

Smit Patel
Featuring
Smit Patel
Director of Digital Medicine at DiMe
Digital Therapeutics (DTx)
9th June @ 10:45AM EDT

B2B2C Models for DTx Products

Most digital therapeutics (DTx) companies opt to pursue B2B business models, such as partnerships with pharma, employers or payers. Join this meeting to discuss this further with other members working in this space.

Eugene Borukhovich
Featuring
Eugene Borukhovich
COO & Co-Founder of YourCoach.Health
Digital Therapeutics (DTx)
8th June @ 10:30AM EDT

Masterclass: How to Navigate DiGA in Germany? A Real Experience from a Digital Health Company

Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Join this interactive masterclass led by Dr Victor Stephani to dive deeper into this topic and discuss the matter further with your peers in this field.

Dr. Victor Stephani
Featuring
Dr. Victor Stephani
Chief of Staff, HelloBetter